Condensed Consolidated Statement of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Operating activities:
Net loss	$ (10,622)	$ (4,300)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization	6,571	6,613
Amortization of deferred gain	(390)	(62)
Amortization of deferred financing costs and debt discount	1,710	1,512
Gain on sale of fixed assets	(189)	0
Unrealized loss on debt conversion option	0	11,340
Unrealized (gains) losses on commodity hedges	1,031	(434)
Equity in earnings of joint venture	(1,469)	(3,008)
Dividends from joint venture	2,692	678
Deferred tax benefit	(417)	(1,024)
Share-based compensation expense	311	1,445
Excess tax benefits from share-based payment arrangements	(242)	0
Increase (decrease) from changes in, net of acquisition:
Accounts receivable	(25,763)	(15,476)
Inventories	32,272	(60,734)
Prepaid expenses and other current assets	(395)	(4,198)
Other assets	55	(875)
Prepaid pension costs	(1,219)	(452)
Accounts payable	23,344	28,983
Income taxes payable and receivable	(1,218)	5,789
Accrued liabilities	6,299	9,670
Postretirement benefit obligations and other liabilities	224	173
Net cash from (used in) operating activities	32,585	(24,360)
Investing activities:
Capital expenditures	(1,881)	(3,124)
Proceeds from sale of fixed assets	468	0
Net cash used in investing activities	(1,413)	(3,124)
Financing activities:
Proceeds from long-term debt	106,500	150,228
Repayments of long-term debt	(137,869)	(135,405)
Payment of debt issue costs	0	(1,313)
Proceeds from Stock Options Exercised	409	0
Excess tax benefits from share-based payment arrangements	242	0
Net cash (used in) from financing activities	(30,718)	13,510
Effect of exchange rate changes on cash and cash equivalents	(691)	4
Net decrease in cash and cash equivalents	(237)	(13,970)
Cash and cash equivalents - beginning of year	21,607	30,524
Cash and cash equivalents - end of period	$ 21,370	$ 16,554